Journal of Neuroinflammation (Feb 2023)
Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice
Abstract
Highlights ICOS agonist antibody (ICOSaa) promotes paclitaxel-evoked pain resolution in female mice. DRG T cells appear to enter an anti-inflammatory phenotype by ICOSaa treatment. ICOSaa treatment increases DRG levels of IL-10 cytokine. ICOSaa effects in female mice are blocked by IL-10 sequestering treatment.
Keywords